Matches in SemOpenAlex for { <https://semopenalex.org/work/W1839509370> ?p ?o ?g. }
- W1839509370 endingPage "819" @default.
- W1839509370 startingPage "789" @default.
- W1839509370 abstract "Context: This article compares the United Kingdom's and the United States’ experiences with expensive cancer drugs to illustrate the challenges posed by new, extremely costly, medical technologies. Methods: This article describes British and American coverage, access, and cost‐sharing policies with regard to expensive cancer drugs and then compares the costs of eleven such drugs to British patients, American Medicare beneficiaries, and American patients purchasing the drugs in the retail market. Three questions posed by these comparisons are then examined: First, which system is fairer? In which system are cancer patients better off? Assuming that no system can sustainably provide to everyone at least some expensive cancer drugs for some clinical indications, what challenges does each system face in making these difficult determinations? Findings: In both the British and American health care systems, not all patients who might benefit from or desire access to expensive cancer drugs have access to them. The popular characterization of the United States, where all cancer drugs are available for all to access as and when needed, and that of the British NHS, where top‐down population rationing poses insurmountable obstacles to British patients’ access, are far from the reality in both countries. Conclusions: Key elements of the British system are fairer than the American system, and the British system is better structured to deal with difficult decisions about expensive end‐of‐life cancer drugs. Both systems face common ethical, financial, organizational, and priority‐setting challenges in making these decisions." @default.
- W1839509370 created "2016-06-24" @default.
- W1839509370 creator A5007544977 @default.
- W1839509370 creator A5022466870 @default.
- W1839509370 creator A5038460900 @default.
- W1839509370 creator A5049431862 @default.
- W1839509370 creator A5083145429 @default.
- W1839509370 date "2009-12-01" @default.
- W1839509370 modified "2023-10-16" @default.
- W1839509370 title "Expensive Cancer Drugs: A Comparison between the United States and the United Kingdom" @default.
- W1839509370 cites W139735624 @default.
- W1839509370 cites W1970222722 @default.
- W1839509370 cites W1974362311 @default.
- W1839509370 cites W1984321527 @default.
- W1839509370 cites W1991123951 @default.
- W1839509370 cites W1997009145 @default.
- W1839509370 cites W2010913334 @default.
- W1839509370 cites W2012894436 @default.
- W1839509370 cites W2018891937 @default.
- W1839509370 cites W2022845081 @default.
- W1839509370 cites W2024622171 @default.
- W1839509370 cites W2025353918 @default.
- W1839509370 cites W2025829030 @default.
- W1839509370 cites W2031664823 @default.
- W1839509370 cites W2032890296 @default.
- W1839509370 cites W2050756280 @default.
- W1839509370 cites W2060973128 @default.
- W1839509370 cites W2083141568 @default.
- W1839509370 cites W2089538394 @default.
- W1839509370 cites W2090009126 @default.
- W1839509370 cites W2093792094 @default.
- W1839509370 cites W2095095509 @default.
- W1839509370 cites W2123272213 @default.
- W1839509370 cites W2132047269 @default.
- W1839509370 cites W2135630936 @default.
- W1839509370 cites W2160887174 @default.
- W1839509370 cites W2165693726 @default.
- W1839509370 cites W2166280716 @default.
- W1839509370 cites W2169561770 @default.
- W1839509370 cites W2308172596 @default.
- W1839509370 cites W2483503335 @default.
- W1839509370 cites W4236466605 @default.
- W1839509370 cites W761282082 @default.
- W1839509370 doi "https://doi.org/10.1111/j.1468-0009.2009.00579.x" @default.
- W1839509370 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2888017" @default.
- W1839509370 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20021586" @default.
- W1839509370 hasPublicationYear "2009" @default.
- W1839509370 type Work @default.
- W1839509370 sameAs 1839509370 @default.
- W1839509370 citedByCount "51" @default.
- W1839509370 countsByYear W18395093702012 @default.
- W1839509370 countsByYear W18395093702013 @default.
- W1839509370 countsByYear W18395093702014 @default.
- W1839509370 countsByYear W18395093702015 @default.
- W1839509370 countsByYear W18395093702016 @default.
- W1839509370 countsByYear W18395093702017 @default.
- W1839509370 countsByYear W18395093702018 @default.
- W1839509370 countsByYear W18395093702019 @default.
- W1839509370 countsByYear W18395093702020 @default.
- W1839509370 countsByYear W18395093702021 @default.
- W1839509370 countsByYear W18395093702023 @default.
- W1839509370 crossrefType "journal-article" @default.
- W1839509370 hasAuthorship W1839509370A5007544977 @default.
- W1839509370 hasAuthorship W1839509370A5022466870 @default.
- W1839509370 hasAuthorship W1839509370A5038460900 @default.
- W1839509370 hasAuthorship W1839509370A5049431862 @default.
- W1839509370 hasAuthorship W1839509370A5083145429 @default.
- W1839509370 hasBestOaLocation W18395093702 @default.
- W1839509370 hasConcept C144133560 @default.
- W1839509370 hasConcept C160735492 @default.
- W1839509370 hasConcept C162324750 @default.
- W1839509370 hasConcept C162853370 @default.
- W1839509370 hasConcept C166957645 @default.
- W1839509370 hasConcept C205649164 @default.
- W1839509370 hasConcept C2775994111 @default.
- W1839509370 hasConcept C2778813691 @default.
- W1839509370 hasConcept C2779343474 @default.
- W1839509370 hasConcept C2908647359 @default.
- W1839509370 hasConcept C2988170871 @default.
- W1839509370 hasConcept C50522688 @default.
- W1839509370 hasConcept C71924100 @default.
- W1839509370 hasConcept C99454951 @default.
- W1839509370 hasConceptScore W1839509370C144133560 @default.
- W1839509370 hasConceptScore W1839509370C160735492 @default.
- W1839509370 hasConceptScore W1839509370C162324750 @default.
- W1839509370 hasConceptScore W1839509370C162853370 @default.
- W1839509370 hasConceptScore W1839509370C166957645 @default.
- W1839509370 hasConceptScore W1839509370C205649164 @default.
- W1839509370 hasConceptScore W1839509370C2775994111 @default.
- W1839509370 hasConceptScore W1839509370C2778813691 @default.
- W1839509370 hasConceptScore W1839509370C2779343474 @default.
- W1839509370 hasConceptScore W1839509370C2908647359 @default.
- W1839509370 hasConceptScore W1839509370C2988170871 @default.
- W1839509370 hasConceptScore W1839509370C50522688 @default.
- W1839509370 hasConceptScore W1839509370C71924100 @default.
- W1839509370 hasConceptScore W1839509370C99454951 @default.
- W1839509370 hasIssue "4" @default.
- W1839509370 hasLocation W18395093701 @default.